Vistagen Therapeutics, Inc. Stock
Stocks
VTGN
US92840H4002
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
16:00:00 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 0.2570 USD | -1.15% |
|
+5.28% | -61.17% |
| Market Cap | 11.54M 9.9M 9.27M 8.49M 15.98M 1.1B 16.04M 110M 42.87M 551M 43.32M 42.38M 1.84B | P/E 2027 * |
-0.18x | P/E 2028 * | -0.17x |
|---|---|---|---|---|---|
| Enterprise Value | -183M -157M -147M -135M -254M -17.5B -255M -1.74B -681M -8.75B -688M -673M -29.19B | EV / Sales 2027 * |
-163x | EV / Sales 2028 * | - |
| Free-Float |
99.62% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript : Vistagen Therapeutics, Inc.
| 1 day | -1.15% | ||
| 1 week | +5.28% | ||
| Current month | +6.64% | ||
| 1 month | +13.52% | ||
| 3 months | -59.64% | ||
| 6 months | -57.52% | ||
| Current year | -61.17% |
| 1 week | 0.24 |  | 0.27 |
| 1 month | 0.22 | | 0.32 |
| Current year | 0.2 | | 0.8 |
| 1 year | 0.2 | | 5.14 |
| 3 years | 0.2 | | 7.35 |
| 5 years | 0.2 | | 97.8 |
| 10 years | 0.2 | | 140.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shawn Singh
CEO | Chief Executive Officer | 63 | 2009-07-31 |
Nick Tressler
DFI | Director of Finance/CFO | 53 | 2025-11-30 |
Angel Angelov
CTO | Chief Tech/Sci/R&D Officer | 57 | 2026-05-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Shawn Singh
BRD | Director/Board Member | 63 | 1999-12-31 |
Jon Saxe
CHM | Chairman | 90 | 2000-05-31 |
Ann Cunningham
BRD | Director/Board Member | 58 | 2019-01-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/29/26 | Free | Director | 40,826 | 0.0995% | ||
| 6/30/26 | Free | Chief Executive Officer | 36,818 | 0.0897% | ||
| 6/30/26 | Free | Chief Financial Officer | 11,712 | 0.0285% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.15% | +5.28% | -91.71% | -95.26% | 11.54M | |
| +3.31% | -3.70% | +61.03% | +103.64% | 70.42B | |
| +1.09% | +3.40% | +51.59% | +93.39% | 65.4B | |
| -1.03% | -1.52% | +6.31% | -5.28% | 28.28B | |
| -0.49% | +5.43% | +54.81% | +13.87% | 26.57B | |
| -2.41% | -7.09% | -8.16% | +455.82% | 27.16B | |
| +0.37% | +0.70% | +37.37% | -15.78% | 20.09B | |
| +1.02% | +6.43% | +269.42% | +420.34% | 20.61B | |
| +0.77% | +0.19% | +8.01% | +520.34% | 15.87B | |
| -1.50% | +1.60% | +44.13% | +151.30% | 13.9B | |
| Average | -0.00% | +1.69% | +43.28% | +164.24% | 28.83B | |
| Weighted average by Cap. | +0.75% | +0.72% | +55.94% | +155.09% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 1.13M 966K 904K 828K 1.56M 108M 1.56M 10.7M 4.18M 53.77M 4.23M 4.13M 179M | - |
| Net income | -61.56M -52.83M -49.43M -45.29M -85.26M -5.88B -85.59M -585M -229M -2.94B -231M -226M -9.81B | -65.79M -56.46M -52.83M -48.4M -91.12M -6.28B -91.46M -625M -244M -3.14B -247M -242M -10.48B |
| Net Debt | -195M -167M -156M -143M -270M -18.6B -271M -1.85B -723M -9.3B -731M -715M -31.03B | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-27 | US$0.2570 | -1.15% | 339,094 |
| 26-08-26 | US$0.2600 | +4.67% | 569,365 |
| 26-08-25 | US$0.2484 | +1.89% | 712,915 |
| 26-08-24 | US$0.2438 | -0.08% | 477,881 |
| 26-08-21 | US$0.2440 | +1.20% | 990,777 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VTGN Stock
Select your edition
All financial news and data tailored to specific country editions
